source Post navigation Do GLP-1s Lower VTE Risk in People With Type 2 Diabetes? – Medscape Bio-Path Holdings Outlines Rationale for Development of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes Patients – The Manila Times